Results for the substance didanosine:

DIDANOZINA AUROBINDO 250mg gastro-resistant capsules

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

P-RF

DIDANOZINA AUROBINDO 400mg gastro-resistant capsules

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

P-RF

VIDEX EC 250mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

P-RF

VIDEX EC 400mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

P-RF

VIDEX EC 200mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

P-RF

VIDEX EC 125mg gastro-resistant capsules BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

P-RF

VIDEX 100mg dispersible / chewable tablets BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

P-RF

VIDEX 150mg dispersible / chewable tablets BRISTOL MYERS SQUIBB ORIGINAL
MEDICINE

Chemical substance: didanosine

ATC code: J05AF02 • Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

P-RF